another news portal
The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal
Researchers from NYU Abu Dhabi, in collaboration with Cleveland Clinic Abu Dhabi, have developed a tiny, injectable medical device that introduces a new approach to
Traumatic brain injuries (TBI) – even mild concussions – may trigger a chain reaction in the brain that disrupts neuronal communication, long-term memory, and cognition
We tend to assume that emotionally charged words are more likely to grab our attention. An insult shouted across a crowded room or a disturbing
Primary hyperparathyroidism (PHPT) is a common endocrine disorder characterized by excessive secretion of parathyroid hormone (PTH).
A carefully designed metal-free carbon monoxide prodrug may help prevent some of the deadliest forms of cancer from spreading, according to researchers at Weill Cornell
The walkout had been due to start at 07:00 BST on Monday and last until Friday.
Nearly 6% of U.S. middle and high school students vape
A Southampton Solent University student is set to graduate with two jobs already secured, one with the Ambulance Service and one delivering trauma simulation training
Cancer drugs can shrink fast-growing tumors. But sometimes a few tumor cells survive. These “persister” cells seed new tumors, forcing cancer patients into arduous cycles
Malcolm Brenner, an internationally recognized physician‑scientist renowned for his leadership in cell and gene therapy, has been tapped to lead the newly formed Houston Methodist
The University of Oklahoma has received an $11.5 million award from the National Institutes of Health to establish the Oklahoma Center of ImmunoEngineering, a new
In the split second after you hear a noise, your brain is already making a potentially life-or-death deduction: Did I do that, or did something
